Cyclin D1 overexpression in primary hypopharyngeal carcinomas

Area of Science:

• Oncology
• Molecular Pathology

Background:

• Hypopharyngeal squamous cell carcinomas (HPCS) have a poor prognosis, with limited value of conventional prognostic factors.
• Identifying new prognostic factors for HPCS is crucial for understanding tumor aggressiveness.
• Cyclin D1 protooncogene amplification and overexpression are implicated in various malignancies and tumor progression.

Purpose of the Study:

• To immunohistochemically evaluate cyclin D1 gene overexpression in primary HPCS.
• To assess the correlation between cyclin D1 overexpression, proliferation index (MIB-1), and clinicopathologic factors.
• To determine the prognostic value of cyclin D1 and MIB-1 in HPCS.

Main Methods:

• Immunohistochemical analysis of cyclin D1 and MIB-1 (Ki-67) on 42 primary HPCS biopsy specimens.
• Detection using monoclonal antibodies via the streptavidin-biotin method.
• Statistical analysis of correlations between cyclin D1, MIB-1, clinicopathologic factors (stage, grade, lymph node metastasis), and survival.

Main Results:

• Cyclin D1 overexpression (≥20% immunoreactivity) was observed in 54.8% of HPCS cases.
• Cyclin D1 overexpression correlated with cervical lymph node metastasis (P=0.037) but not stage, grade, or proliferation index.
• Cyclin D1-negative tumors showed significantly better prognosis (P=0.023), especially with multimodality treatment.
• MIB-1 labeling index did not correlate with clinicopathologic parameters or survival.

Conclusions:

• Cyclin D1 immunohistochemical staining is a valuable prognostic factor for HPCS.
• Cyclin D1 status can aid in determining optimal individualized treatment strategies for HPCS.
• MIB-1 labeling index has no apparent clinical significance in HPCS prognosis.